Your browser doesn't support javascript.
loading
IL-33 Is Essential for Adjuvant Effect of Hydroxypropyl-ß-Cyclodexrin on the Protective Intranasal Influenza Vaccination.
Kobari, Shingo; Kusakabe, Takato; Momota, Masatoshi; Shibahara, Takayuki; Hayashi, Tomoya; Ozasa, Koji; Morita, Hideaki; Matsumoto, Kenji; Saito, Hirohisa; Ito, Shuichi; Kuroda, Etsushi; Ishii, Ken J.
Afiliación
  • Kobari S; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Kusakabe T; Department of Pediatrics, Graduate School of Medicine, Yokohama City University, Kanagawa, Japan.
  • Momota M; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Shibahara T; Laboratory of Mock-up Vaccine Project, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Hayashi T; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.
  • Ozasa K; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Morita H; Laboratory of Mock-up Vaccine Project, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Matsumoto K; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Saito H; Laboratory of Mock-up Vaccine Project, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Ito S; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center (IFReC), Osaka University, Osaka, Japan.
  • Kuroda E; Laboratory of Adjuvant Innovation, Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Osaka, Japan.
  • Ishii KJ; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Front Immunol ; 11: 360, 2020.
Article en En | MEDLINE | ID: mdl-32210964
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Adyuvantes Inmunológicos / Interleucina-33 / 2-Hidroxipropil-beta-Ciclodextrina Límite: Animals Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la Influenza / Adyuvantes Inmunológicos / Interleucina-33 / 2-Hidroxipropil-beta-Ciclodextrina Límite: Animals Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Suiza